MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expenses and
other current assets
$853,300K
Inventories
$1,686,800K
Accounts receivable, net
$2,052,800K
Marketable securities
$1,523,300K
Cash and cash
equivalents
$5,084,800K
Other assets
$1,236,600K
Long-term marketable
securities
$5,712,300K
Operating lease assets
$1,562,700K
Deferred tax assets
$2,897,900K
Other intangible
assets, net
$424,200K
Goodwill
$1,088,000K
Property and equipment,
net
$1,520,300K
Total current assets
$11,201,000K
Total assets
$25,643,000K
Total liabilities and
shareholders equity
$25,643,000K
Total shareholders
equity
$18,665,800K
Total liabilities
$6,977,200K
Accumulated other
comprehensive (loss) income
-$15,900K
Retained earnings
$13,560,000K
Additional paid-in capital
$5,119,200K
Other long-term
liabilities
$1,269,500K
Long-term operating lease
liabilities
$1,846,500K
Total current
liabilities
$3,861,200K
Common stock, 0.01 par
value 500,000,000...
$2,500K
Other current
liabilities
$428,300K
Accrued expenses
$2,971,200K
Accounts payable
$461,700K
Back
Back
Balance Sheet
source: myfinsight.com
logo-vertex-inc-svg copy-svg
VERTEX PHARMACEUTICALS INC MA (VRTX)
logo-vertex-inc-svg copy-svg
VERTEX PHARMACEUTICALS INC MA (VRTX)